ELUTIA INC. - CLASS A

Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope

20 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023

15 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference

27 Feb 2023 07:15:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results

09 Jan 2023 07:15:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation

15 Dec 2022 07:00:01 By Nasdaq GlobeNewswire

Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock

01 Dec 2022 08:04:00 By Nasdaq GlobeNewswire

Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock

30 Nov 2022 15:08:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in Upcoming Investor Conferences

21 Nov 2022 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

14 Nov 2022 15:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022

07 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors

24 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets

11 Oct 2022 15:35:48 By Nasdaq GlobeNewswire

Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer

26 Aug 2022 08:00:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

17 Aug 2022 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet

11 Aug 2022 15:05:02 By Nasdaq GlobeNewswire

Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings

10 Aug 2022 17:56:35 By Nasdaq GlobeNewswire

Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer

09 Aug 2022 16:57:55 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022

28 Jul 2022 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO

21 Jun 2022 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results

09 May 2022 15:05:02 By Nasdaq GlobeNewswire